1. Home
  2. XENE vs NMRK Comparison

XENE vs NMRK Comparison

Compare XENE & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • NMRK
  • Stock Information
  • Founded
  • XENE 1996
  • NMRK 1929
  • Country
  • XENE Canada
  • NMRK United States
  • Employees
  • XENE N/A
  • NMRK N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • NMRK Real Estate
  • Sector
  • XENE Health Care
  • NMRK Finance
  • Exchange
  • XENE Nasdaq
  • NMRK Nasdaq
  • Market Cap
  • XENE 2.4B
  • NMRK 2.4B
  • IPO Year
  • XENE 2014
  • NMRK 2017
  • Fundamental
  • Price
  • XENE $35.99
  • NMRK $16.73
  • Analyst Decision
  • XENE Strong Buy
  • NMRK Strong Buy
  • Analyst Count
  • XENE 10
  • NMRK 5
  • Target Price
  • XENE $53.20
  • NMRK $17.50
  • AVG Volume (30 Days)
  • XENE 932.8K
  • NMRK 1.6M
  • Earning Date
  • XENE 08-11-2025
  • NMRK 07-30-2025
  • Dividend Yield
  • XENE N/A
  • NMRK 0.72%
  • EPS Growth
  • XENE N/A
  • NMRK 44.43
  • EPS
  • XENE N/A
  • NMRK 0.36
  • Revenue
  • XENE $7,500,000.00
  • NMRK $2,983,234,000.00
  • Revenue This Year
  • XENE N/A
  • NMRK $13.64
  • Revenue Next Year
  • XENE $253.71
  • NMRK $9.67
  • P/E Ratio
  • XENE N/A
  • NMRK $46.49
  • Revenue Growth
  • XENE N/A
  • NMRK 17.28
  • 52 Week Low
  • XENE $26.74
  • NMRK $9.65
  • 52 Week High
  • XENE $46.00
  • NMRK $16.77
  • Technical
  • Relative Strength Index (RSI)
  • XENE 69.83
  • NMRK 84.48
  • Support Level
  • XENE $32.78
  • NMRK $14.68
  • Resistance Level
  • XENE $34.63
  • NMRK $15.50
  • Average True Range (ATR)
  • XENE 1.48
  • NMRK 0.53
  • MACD
  • XENE 0.45
  • NMRK 0.17
  • Stochastic Oscillator
  • XENE 79.01
  • NMRK 98.72

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About NMRK Newmark Group Inc.

Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.

Share on Social Networks: